CareLit Fachartikel

Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities

S Rosenkranz, R Channick, K Chin, B Jenner, S Gaine, N Galie, HA Ghofrani, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, O Sitbon, V Tapson, I Lang · Pneumologie · 2020 · Heft S 01 S 01

Dokument
1214461
CareLit-ID
Jahr
2020
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
S Rosenkranz, R Channick, K Chin, B Jenner, S Gaine, N Galie, HA Ghofrani, MM Hoeper, V McLaughlin, R Preiss, L Rubin, G Simonneau, O Sitbon, V Tapson, I Lang
Ausgabe
Heft S 01 S 01 / 2020
Jahrgang 74
Seiten
–
Erschienen: 2020-03-01 00:00:00
ISSN
0934-8387
DOI
10.1055/s-0039-3403192

Zusammenfassung

Efficacy and safety of selexipag in pulmonary arterial hypertension (PAH) patients with and without significant cardiovascular (CV) comorbidities

Schlagworte

Efficacy Safety Selexipag Pulmonary Arterial Hypertension Patients Without Significant Cardiovascular Comorbidities Pneumologie